Disclosure 0002001011-26-000115-6

SEC FORM 4

$9,241,228.66

LIGAND PHARMACEUTICALS INC (LGND)

Sale of 31,641 shares at $292.065 per share.

Reporting Person Espinoza Octavio · Officer Title Chief Financial Officer · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0002001011-26-000115 · filed 2026-08-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "LIGAND PHARMACEUTICALS INC (LGND)." Disclosed 2026-08-14. https://desqlong.com/cards/0002001011-26-000115-6 (retrieved 2026-09-26).